rimiterol has been researched along with Bronchial-Spasm* in 3 studies
1 review(s) available for rimiterol and Bronchial-Spasm
| Article | Year |
|---|---|
A brief review of sympathomimetic bronchodilators and a description of a new selective agent, rimiterol hydrobromide.
The development of beta2-specific sympathomimetic bronchodilators (rimiterol, salbutamol, terbutaline) has made the basic treatment of asthmatic patients more safe and effective. Despite that, the asthmatics should be under careful control and all patients should be taught the correct way to use their bronchodilator aerosols. If a sympathomimetic drug has lost its effectiveness, the patient should be able to have easy contact to the treating physician or outpatient department. Topics: Adrenergic beta-Agonists; Aerosols; Animals; Asthma; Bronchial Spasm; Bronchodilator Agents; Catechols; Humans; Piperidines | 1978 |
1 trial(s) available for rimiterol and Bronchial-Spasm
| Article | Year |
|---|---|
A comparison of isoprenaline, salbutamol, and rimiterol inhalation on skin temperature, heart rate, and respiration in man.
Topics: Adrenergic beta-Agonists; Adult; Aerosols; Amino Alcohols; Bronchial Spasm; Butylamines; Catechols; Clinical Trials as Topic; Electrocardiography; Female; Heart Rate; Histamine; Humans; Isoproterenol; Male; Methanol; Phenethylamines; Piperidines; Respiration; Skin Temperature; Sympathomimetics; Vasodilator Agents | 1972 |
1 other study(ies) available for rimiterol and Bronchial-Spasm
| Article | Year |
|---|---|
A comparison of rimiterol and salbutamol by inhalation at high and low dose in asthmatic patients.
Rimiterol hydrobromide (Pulmadil) has been shown to have a dose-related bronchodilator effect; the optimum dose by inhalation appears to lie between 200 and 1,000 microgram. When given to a group of asthmatic patients at 'recommended' and 5--10 times 'recommended' dose by aerosol, cardiovascular effects were minimal and of a magnitude similar to that of salbutamol given in the same dosages to the same patients. The very rapid bronchodilator effect of rimiterol would appear to make the drug particularly suitable for the treatment of patients with intermittent asthmatic attacks, before exercise in patients with exercise-induced asthma and for bronchodilatation before using inhaled sodium cromoglycate or corticosteroid aerosols. Topics: Aerosols; Albuterol; Asthma; Blood Pressure; Bronchial Spasm; Catechols; Heart Rate; Humans; Peak Expiratory Flow Rate; Piperidines | 1978 |